A TSHRN1201 Sub-study-To Evaluate the Effects of add-on Ranolazine on Exercise Tolerance and Angina Frequency

NCT03401502 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Angina

Interventions

DRUG: Ranolazine
DRUG: Placebos

Sponsor

TSH Biopharm Corporation Limited